GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that act on hormonal pathways involved in appetite regulation, satiety, and blood glucose control.

​

Patients may recognize brand names such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. These medications are not interchangeable, are not appropriate for every patient, and must be assessed and prescribed by a licensed healthcare professional.

​

At Edgemont Weight Management Clinic:

• GLP-1 therapy is never initiated without a clinical assessment

• It is used as one component of a broader medical weight management plan

• Ongoing monitoring and follow-up are required

• Medications are not positioned as cosmetic, rapid, or guaranteed solutions

GLP-1–supported care may be considered for adults who:

• Have a body mass index (BMI) ≥30 kg/m², or

• Have a BMI ≥27 kg/m² with weight-related health conditions such as hypertension, dyslipidemia, or prediabetes

​

Eligibility is determined through professional assessment and clinical judgment.

02

Optifast® Supported Medical Weight Management

Optifast® is a nutritionally complete, medically formulated meal replacement program that may be used as part of a time-limited, medically supervised dietary phase.

​

Because this approach involves significant caloric restriction, clinical oversight is essential.

​

At Edgemont Weight Management Clinic:

• Optifast® is never started without assessment

• It is not appropriate for every patient

• It is not used as a permanent or standalone solution

• It is always paired with follow-up and structured transition planning back to regular nutrition

​

Optifast®-supported care may be considered for adults who:

• Have obesity or significant weight-related health risks

• Have not achieved adequate results with lifestyle-based approaches alone

• Require a highly structured dietary intervention under medical supervision

​

All use of Optifast® occurs within a broader medical weight management plan focused on safety and sustainability.